Leaderboard

En | De
No articles selected!     View Cart  
You are here: Oncology » Respiratory Tract 21. September 2023
Search
medline.ch
Respiratory Tract
Advanced search
Dermatology
Endocrinology
Nutrition
Gastroenterology
Gynecology
Haematology
Infectious diseases
Cardiovascular Diseases
Musculoskeletal Diseases
Neurology
Oncology
Musculoskeletal System
Blood
Endocrine System
Gynecologic Neoplasms
Skin
Gastrointestinal
ORL
Respiratory Tract
Urologic Neoplasms
CNS
ORL
Pediatrics
Psychiatry
Respiratory Tract
Sports
Urology-Nephrology
Rect Top
Zoom: Zoom In Zoom Out

   Page 1 of 6799  Previews Next
   
   Articles 1 - 20 / 135961  
   
Sex and anti-inflammatory treatment affect outcome of melanoma and non-small cell lung cancer patients with rheumatic immune-related adverse events.
J Immunother Cancer
Gente K, Diekmann L, Daniello L, Will J, Feisst M, Olsavszky V, Günther J, Lorenz HM, Souto-Carneiro MM, Hassel JC, Christopoulos P, Leipe J.
PMID: 37730272 [PubMed - in process]


Prevalence of oncogenic driver mutations in Hispanics/Latin patients with lung cancer. A systematic review and meta-analysis.
Lung Cancer
Parra-Medina R, Pablo Castañeda-González J, Montoya L, Paula Gómez-Gómez M, Clavijo Cabezas D, Plazas Vargas M.
PMID: 37729688 [PubMed - as supplied by publisher]


Should we be screening for COPD? - looking through the lens of lung cancer screening.
Expert Rev Respir Med
Young RP, Scott RJ.
PMID: 37728077 [PubMed - as supplied by publisher]


Metallodrugs in the battle against non-small cell lung cancer: unlocking the potential for improved therapeutic outcomes.
Front Pharmacol
Xu X, Dai F, Mao Y, Zhang K, Qin Y, Zheng J.
PMID: 37727388 [PubMed]


Current status of clinical trial research and application of immune checkpoint inhibitors for non-small cell lung cancer.
Front Oncol
Wang F, Xia T, Li Z, Gao X, Fang X.
PMID: 37727216 [PubMed]


Immunologic constant of rejection as a predictive biomarker of immune checkpoint inhibitors efficacy in non-small cell lung cancer.
J Transl Med
Mogenet A, Finetti P, Denicolai E, Greillier L, Boudou-Rouquette P, Goldwasser F, Lumet G, Ceccarelli M, Birnbaum D, Bedognetti D, Mamessier E, Barlesi F, Bertucci F, Tomasini P.
PMID: 37726776 [PubMed - in process]


Sleep disturbances and the risk of lung cancer: a meta-epidemiological study.
BMC Cancer
Zhou T, Wang Z, Qiao C, Wang S, Hu S, Wang X, Ma X, Wang D, Li J, Li Z, Hou W.
PMID: 37726707 [PubMed - in process]


An Update on Potential Molecular Biomarkers of Dietary Phytochemicals Targeting Lung Cancer Interception and Prevention.
Pharm Res
Peter RM, Chou PJ, Shannar A, Patel K, Pan Y, Dave PD, Xu J, Sarwar MS, Kong AT.
PMID: 37726406 [PubMed - as supplied by publisher]


Lobar or sublobar resection for early-stage second primary lung cancer ≤ 3 cm in size: a SEER population-based study.
J Cancer Res Clin Oncol
Zhao K, Xia C, Qiu M, Yang Z, Cui T, Song T, Li S, Mei H, Zheng Y, Wang H.
PMID: 37725243 [PubMed - as supplied by publisher]


Potential of ChatGPT and GPT-4 for Data Mining of Free-Text CT Reports on Lung Cancer.
Radiology
Fink MA, Bischoff A, Fink CA, Moll M, Kroschke J, Dulz L, Heußel CP, Kauczor HU, Weber TF.
PMID: 37724963 [PubMed - in process]


Incidence and Survival for Patients Diagnosed With Breast, Colorectal, and Lung Cancer in an Integrated System.
Perm J
Hahn EE, Ritzwoller DP, Munoz-Plaza CE, Gander J, Kushi LH, McMullen C, Oshiro C, Roblin DW, Wernli KJ, Staab J.
PMID: 37724894 [PubMed - as supplied by publisher]


Impact of liver metastases status on survival outcomes of first-line immunotherapy in extensive stage small cell lung cancer: a systematic review and meta-analysis.
Aging (Albany NY)
Lin Y, Jiang W, Su CY, Pan XB.
PMID: 37724893 [PubMed - as supplied by publisher]


Nomogram based on clinical characteristics and radiological features for the preoperative prediction of spread through air spaces in patients with clinical stage IA non-small cell lung cancer: a multicenter study.
Diagn Interv Radiol
Wang Y, Lyu D, Zhang D, Hu L, Wu J, Tu W, Xiao Y, Fan L, Liu S.
PMID: 37724737 [PubMed - as supplied by publisher]


The efficacy and safety of chemo-free therapy in epidermal growth factor receptor tyrosine kinase inhibitor-resistant advanced non-small cell lung cancer: A single-arm, phase II study.
Cancer Med
Zhang S, Yang L, Yang Y, Yang G, Xu H, Niu X, Wang Y.
PMID: 37723846 [PubMed - as supplied by publisher]


Sintilimab plus anlotinib as second- or third-line therapy in metastatic non-small cell lung cancer with uncommon epidermal growth factor receptor mutations: A prospective, single-arm, phase II trial.
Cancer Med
Chen K, Xu Y, Huang Z, Yu X, Hong W, Li H, Xu X, Lu H, Xie F, Chen J, Xu Y, Fan Y.
PMID: 37723837 [PubMed - as supplied by publisher]


Comparative analysis of methodologies for predicting overall survival in patients with non-small cell lung cancer based on the number and rate of resected positive lymph nodes: A study based on the SEER database for 2010 through 2019.
Clin Respir J
Guo Q, Hu S, Wang S, Su L, Zhang W, Xu J, Wei Y.
PMID: 37723579 [PubMed - as supplied by publisher]


Medico-economic impact of thoracoscopy versus thoracotomy in lung cancer: multicentre randomised controlled trial (Lungsco01).
BMC Health Serv Res
Soilly AL, Aho Glélé LS, Bernard A, Abou Hanna H, Filaire M, Magdaleinat P, Marty-Ané C, Tronc F, Grima R, Baste JM, Thomas PA, Richard De Latour B, Pforr A, Pagès PB.
PMID: 37723516 [PubMed - indexed for MEDLINE]


Bone-modifying agents for non-small-cell lung cancer patients with bone metastases during the era of immune checkpoint inhibitors: A narrative review.
Semin Oncol
Kim J, Jeong C, Lee J, Ha J, Baek KH, Kim S, An TJ, Park CK, Yoon HK, Lim JU.
PMID: 37723018 [PubMed - as supplied by publisher]


Induction Chemoimmunotherapy with Surgery versus Concurrent Chemoradiation followed by Immunotherapy for Stage III-N2 Non-small Cell Lung Cancer.
J Thorac Cardiovasc Surg
Kumar A, Srinivasan D, Potter A, Mathey-Andrews C, Lanuti M, Martin LW, Jeffrey Yang CF.
PMID: 37722622 [PubMed - as supplied by publisher]


Q-TWiST analysis of survival benefits with brigatinib versus crizotinib in patients with anaplastic lymphoma kinase-positive non-small cell lung cancer based on results of the ALTA-1L trial.
Lung Cancer
Garcia Campelo MR, Wan Y, Lin HM, Chen T, Shen J, Zhang P, Camidge DR.
PMID: 37722340 [PubMed - as supplied by publisher]


   
   Articles 1 - 20 / 135961    Page 1 of 6799  Previews Next

 
Rect Bottom
Adserver Footer
 

Username

Password

 

 

Forgot your username or password?

 

New User? Sign Up

Register to My Medline!

 

Learn more about the My Medline experience

more >>

  Time frame  
   

Sky right 1